Search
Isavuconazonium
go.drugbank.com/drugs/DB06636ApprovedInvestigational[A38834] It is the prodrug form of isavuconazole, the active moiety, and it is available in oral and parenteral formulations. … Isavuconazonium is a second-generation triazole antifungal approved on March 6, 2015 by the FDA and July 2015 by the EMA for the treatment of adults with invasive aspergillosis and invasive mucormycosis
Bedaquiline
go.drugbank.com/drugs/DB08903ApprovedInvestigational[A261856] Currently, bedaquiline is the last-line anti-TB drug and must only be used in an appropriate combination regimen.[L48506,A261866] … [A261856,A261861] It is the first drug that was approved in the last 40 years by the FDA for TB unresponsive to current treatments on the market.
Bone Diseases, Infectious
go.drugbank.com/conditions/DBCOND0076351Synonyms: Bone Infection, Infection in BoneSevere Bone Resorption
go.drugbank.com/conditions/DBCOND0134282Drugs: CholecalciferolSynonyms: Severe Bone ResorptionPlerixafor
go.drugbank.com/drugs/DB06809ApprovedInvestigational[A7117,L45678] It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma to stimulate their immune system. … [A7115] Plerixafor has orphan drug status in the United States and European Union and was approved by the US Food and Drug Administration on December 15, 2008.[A7117,L45678]
Bronopol
go.drugbank.com/drugs/DB13960ApprovedThe agent is largely available commercially as an antibacterial for a variety of industrial purposes while it is predominantly available for purchase as a pet animal litter antibacterial at the domestic … L4873] and in other products where it may not primarily be used in the role of a non-medicinal preservative antimicrobial [L4874].
Categories: Compounds used in a research, industrial, or household settingVadadustat
go.drugbank.com/drugs/DB12255ApprovedInvestigational[L39610,L46936,L46951] Vadadustat was approved by the FDA in March 2024.[L50371] … [A244145,A244155] It was first approved in Japan in 2020,[L50371] and in April 2023, it was approved by the EMA for the treatment of symptomatic anemia associated with CKD in adults on chronic maintenance
Synonyms: N-(5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl)glycine, Glycine, N-((5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl)carbonyl)-Phenformin
go.drugbank.com/drugs/DB00914ApprovedWithdrawnAlthough it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. … (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
Categories: Drugs Used in DiabetesGallium nitrate
go.drugbank.com/drugs/DB05260ApprovedInvestigational[A260816] Gallium nitrate is reported to possess antiresorptive and hypocalcemic effects on bone. … [L47726] Apart from cancer-related hypercalcemia, gallium nitrate has been studied in arthritis, autoimmune disorders, and tumours.[A260830]
Categories: Bone Resorption InhibitionPhenyltoloxamine
go.drugbank.com/drugs/DB11160ApprovedIt is available in combination products that also contain other analgesics and antitussives such as acetaminophen. … barrier and causing tranquilizing effects at CNS histamine receptors, many of the drug's specific pharmacokinetics are not readily available - perhaps also because many early (phenyltoloxamine was involved